Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug
BACKGROUND AND OBJECTIVES: Triptans are effective drugs for the acute treatment of migraine. However, 30-40% of the patients commonly present recurrence before 24 hours therefore requiring another dose. Nonsteroidal anti-inflammatory drugs (NSAID) such as tolfenamic acid and naproxen sodium combined...
Main Authors: | Krymchantowski Abouch V., Barbosa Jackeline Soraya |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2001-01-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2001000500010 |
Similar Items
-
Triptans in treatment of migraine
by: V. A. Golovacheva, et al.
Published: (2015-12-01) -
Comparative evaluation of the efficiency of a sumatriptan/dexketoprofen combination versus sumatriptan monotherapy in the treatment of a migraine attack
by: K. V. Skorobogatykh, et al.
Published: (2018-11-01) -
Migraine in the triptan era: progresses achieved, lessons learned and future developments Migrânea na era dos triptanos: progressos alcançados, lições aprendidas e desenvolvimentos futuros
by: Marcelo E. Bigal, et al.
Published: (2009-06-01) -
Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
by: Karin Zebenholzer, et al.
Published: (2018-05-01) -
Association between response to triptans and response to erenumab: real-life data
by: Ilaria Frattale, et al.
Published: (2021-01-01)